Phibro Animal Health Corporation— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$1.41B
↑+9.3% +$120Mvs FY2024
Total Liabilities
$1.07B
↑+3.3% +$34Mvs FY2024
Equity
$332M
↑+34.7% +$86Mvs FY2024
Cash
$55M
↓-17.3% -$12Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.41B | $1.29B |
| Current Assets | $862M | $746M |
| Cash | $55M | $67M |
| ST Investments | $19M | $0 |
| Receivables | $216M | $192M |
| Inventory | $517M | $427M |
| Other Current | $54M | $60M |
| Non-Current Assets | $543M | $539M |
| PPE | $355M | $338M |
| Goodwill | $60M | $55M |
| Intangibles | $33M | $40M |
| Investments | $0 | $0 |
| Other Non-Current | $95M | $107M |
| Total Liab+Eq | $1.41B | $1.29B |
| Current Liab. | $282M | $233M |
| Accounts Payable | $133M | $99M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $149M | $134M |
| Non-Current Liab. | $791M | $805M |
| Long-Term Debt | $624M | $639M |
| Other LT Liab. | $167M | $166M |
| Equity | $332M | $247M |
| Retained Earnings | $317M | $244M |
| Other Equity | $15M | $2M |
QuarterCharts · SEC EDGAR data · PAHC · Comparing FY2025 vs FY2024